Impella 5.0 support before, during, and after surgical ventriculoplasty following acute myocardial infarction in the COVID-19 era: a case report.
Martina BrianiLucia TorraccaGiuseppe CrescenziAlessandro BarbonePublished in: European heart journal. Case reports (2021)
To date, Impella use in cardiothoracic surgery has been described in case of ventricular septal rupture or as a bridge to permanent LV assist device. In our case, Impella 5.0 was implanted, used as a bridge to surgery, and as postoperative support in a patient with evolving cardiogenic shock due to LV aneurysm and depressed LV ejection fraction following acute MI, in the difficult setting of the COVID-19 pandemic.
Keyphrases
- ejection fraction
- minimally invasive
- acute myocardial infarction
- coronary artery bypass
- extracorporeal membrane oxygenation
- aortic stenosis
- left ventricular
- left ventricular assist device
- coronavirus disease
- sars cov
- percutaneous coronary intervention
- liver failure
- respiratory failure
- surgical site infection
- coronary artery
- patients undergoing
- case report
- aortic dissection
- atrial fibrillation
- hepatitis b virus
- coronary artery disease
- aortic valve